The largest database of trusted experimental protocols

Massarray typer version 4

Manufactured by Labcorp
Sourced in Germany

The MassARRAY Typer version 4.0 is a laboratory instrument designed for nucleic acid analysis. It utilizes matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry technology to identify and quantify specific nucleic acid sequences.

Automatically generated - may contain errors

4 protocols using massarray typer version 4

1

Genomic DNA Extraction and SNP Genotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
As described previously (Khosla et al., 1999 (link)), total genomic DNA was extracted from young fresh leaves (3 g) taken from the parental cultivars, RILs, first F1, first F2, second F1, and second F2 plants using guanidine hydrochloride (Sigma-Aldrich) and proteinase K (QIAGEN). Multiplex assays for 513 SNPs, distributed throughout the genome, were designed (Supplementary Table 2) using Sequenom Assay Design 3.1 (Sequenom). Genotyping was conducted using the Sequenom MassARRAY system (Oeth et al., 2009 (link)). Multiplex PCR, followed by template-directed single-base extension at each SNP, was conducted using the MassARRAY iPLEX Gold kit (Sequenom), following the instructions of the manufacturer. Genotypes were determined using MassARRAY Typer version 4.0 (Sequenom).
+ Open protocol
+ Expand
2

Genotyping Using MassARRAY Platform

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA from peripheral blood was extracted using QIAamp DNA blood midi kit (Qiagen, Valencia, CA). Genotyping was performed using iPLEX GOLD chemistry and MassARRAY platform (Sequenom, San Diego, CA). PCR assay and iPLEX single-base extension primers were designed by the Assay Design Suite of Sequenom. 10 ng of genomic DNA was used as template for the PCR amplification, followed by shrimp alkaline phosphatase and primer extension steps using Sequenom's protocol and reagents. iPLEX GOLD assay (Sequenom, San Diego, CA) is a primer extension process discriminating sequence differences at the single nucleotide level. Different mass signals for the two alleles between extension products can be captured by the highly accurate MALDI-TOF-based system. Raw data were visualized and processed with MassARRAY Typer Version 4.0 (Sequenom, San Diego, CA).
In regards to genotyping quality control, we used the following criteria as a measure of acceptable genotyping: (1) overall call rate (by individual or by marker) > 95%; (2) call rate > 95% for each 384-well plate; (3) 30 sample duplicates and 4 blank wells (H 2 O) were included in each 384-well plate; (4) call rate < 5% for the blank wells in each 384-well plate; (5) concordance rate for the duplicates ≥ 99%. The data for any individual or SNP failing the criteria described above were excluded from the further analyses.
+ Open protocol
+ Expand
3

Genotyping Protocol for FADS Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genotyping was performed at the Research Unit of Molecular Epidemiology at Helmholtz Zentrum Munich, Germany, as previously described [25 (link)]. DNA was extracted from the buffy coat of umbilical artery blood by the Puregene DNA isolation kit (Gentra Systems, Hilden, Germany). Genotyping was performed using the iPLEX Gold Chemistry (Sequenom, Hamburg, Germany) and matrix-assisted laser desorption ionization-time of flight mass spectrometry, with methods to detect allelic differences. In brief, locations containing certain SNPs were amplified by polymerase chain reaction, using specific primers. After deactivation by alkaline phosphatase, single-base elongation was performed in accordance to the print order. After salt ion removal by ion switch and elongation reaction, the specimen was transferred to a silicone chip and covered with 3-hydroxypicolinic acid. The differences from specific alleles were measured by the matrix-assisted laser desorption ionization-time of flight mass spectrometry. Allele recognition from SNPs was performed by Mass ARRAY Typer version 4.0.5 (Sequenom, Hamburg, Germany). SNPs for FADS genes were selected based on 3 criteria: (1) the SNP has been studied in previous publications; (2) the SNP candidates being considered are SNPs that have already been demonstrated to be associated with LC-PUFA status; and (3) minor allele frequency (MAF) >10%.
+ Open protocol
+ Expand
4

Genotyping of FADS Gene Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols

FADS1, FADS2, and FADS3 SNP analysis was performed at the Research Unit of Molecular Epidemiology at Helmholtz Zentrum Munich, Germany, as previously described (20 (link)). DNA was extracted from the buffy coat of umbilical artery blood by the Puregene DNA isolation kit (Gentra Systems). Genotyping was performed using iPLEX Gold Chemistry (Sequenom) and matrix-assisted laser desorption ionization-time of flight mass spectrometry, with methods to detect allelic differences. In brief, locations containing certain SNPs were amplified by polymerase chain reaction, using specific primers. After deactivation by alkaline phosphatase, single-base elongation was performed in accordance to the print order. After salt ion removal by ion switch and elongation reaction, the specimen was transferred to a silicone chip and covered with 3-hydroxypicolinic acid. The differences from specific alleles were measured by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Allele recognition from SNPs was performed by Mass ARRAY Typer version 4.0.5 (Sequenom). SNPs for FADS genes were selected based on 3 criteria: 1) the SNP has been studied in previous publications; 2) the SNP candidates being considered are SNPs that have already been shown to be associated with LC-PUFA status; and 3) minor allele frequency (MAF) >10%.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!